Friday, Jun 5 2020 | Time 14:58 Hrs(IST)
  • COVID-19: Second patient recovers after plasma therapy in K'taka
  • Brazilian club Ceara report 17 positive coronavirus cases
  • Another setback to Congress before Gujarat RS polls, third MLA resigns
  • Locust species found in Dakshina Kannada not harmful: Experts
  • Railways is committed to providing world class facilities to its passengers
  • Rare white Albino Python spotted at K'taka's Kavalakatte
  • Quarantined govt employee dies in UP's Etah
  • Bodies of two employees found in hotel's water tank in Thane
  • Under-trial, grocer with no travel history test COVID 19 positive in Guwahati
  • Mah: Hingoli reports six new COVID-19 cases
  • UNSC Election candidature: India sets out priorities
  • Meghalaya yet to decide on reopening of educational institutions
  • SASB performs ‘Pratham Pujan’ at Jammu, no decision yet on starting Amarnath Yatra
  • COVID-19: Two patients die, 50 fresh positive cases reported in AP
  • Covid-19: 59 new cases registered in Aurangabad
Business Economy


ICICI Securities to sell Religare Health Insurance products

ICICI Securities to sell Religare Health Insurance products

Mumbai, Apr 30 (UNI) ICICI Securities Limited has tied up with Religare Health Insurance to sell the latter’s products, a statement here said on Tuesday.

"This would be the third health insurance principal to get added on I-Sec’s platform and the first pure play health insurance company," the statement added.

“We are sure our 4.4 million customers would find this very useful when they are looking at purchasing a health insurance policy. The company would sell insurance on www.icicidirect.com and through its 200+ retail outlets across the country," said ICICI Securities Sr. VP – Products Advisory Group Hariharan M in a statement.

Religare Health Insurance MD & CEO Anuj Gulati in a statement said, “We foresee immense potential from this association with ICICI securities and look forward to being the preferred health insurer for their customers.”

Health insurance penetration in India is in low single digits even as the industry size is pegged at about Rs 50,000 crore per annum. However, owing to various factors like rising awareness and entry of specialized health insurers, the sector has been growing at a CAGR of Rs20% over the past 10 years.

UNI DJK ADG 1629

More News

Shoolini University Enters the Top Slot of THE Awards Asia 2020

05 Jun 2020 | 2:57 PM

SOLAN, India, June 5, 2020 /PRNewswire/ - Ten year old Himachal-based Shoolini University figures in the prestigious Times Higher Education (THE), the World's leading agency for ranking Higher educational Institutions, shortlist for the 'THE Awards Asia 2020'.

see more..

Hublot Launches the BIG BANG e

05 Jun 2020 | 2:56 PM

NYON, Switzerland, June 5, 2020 /PRNewswire/ - Hublot first released the Big Bang in 2005. Since then, this model has come to embody Swiss watchmaking in the third millennium.

see more..

Sun Pharma initiates Phase II clinical trial on AQCH

05 Jun 2020 | 2:54 PM

Mumbai, Jun 5 (UNI) Sun Pharmaceutical Industries said that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19.

see more..
Rupee ends negative at 75 58 against USD

Rupee ends negative at 75 58 against USD

05 Jun 2020 | 2:52 PM

Mumbai, Jun 5 (UNI) The Rupee on Friday closed negative at 75.58, easing by one paisa against the greenback on rising demand for US Dollar by bankers and importers, dealers at Forex Market said.

see more..
Zydus Cadila receives final approval from USFDA for Atazanavir capsules

Zydus Cadila receives final approval from USFDA for Atazanavir capsules

05 Jun 2020 | 2:50 PM

Mumbai, Jun 5 ( UNI) Pharma major Zydus Cadila on Friday said that it has received final approval from the USFDA to market Atazanavir Capsules (Reyataz Capsules) in the strengths of 150 mg, 200 mg and 300 mg.

see more..